|
Health-Seeking Behaviors among Men with Criminal Justice and Substance Abuse Hist
|
5K01CA154861-02
|
$130,185
|
|
Valera, Pamela
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Building capacity in food bank organizations for obesity prevention programs
|
5R21CA150977-02
|
|
|
Dave, Jayna
|
BAYLOR COLLEGE OF MEDICINE
|
|
Heparanase Mechanisms in Brain-metastatic Breast Cancer
|
1R01CA160335-01
|
$297,350
|
|
MARCHETTI, DARIO
|
BAYLOR COLLEGE OF MEDICINE
|
|
Role of Fibroblasts, Myeloid Cells and Matrix in PDAC
|
5U01CA151925-02
|
$648,725
|
|
KALLURI, RAGHU
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Development of Ultrasound-facilitated Formalin-fixed and Paraffin-embedded Tissue
|
5R44CA115041-04
|
$362,500
|
|
Zou, Nianxiang
|
BIO-QUICK CORPORATION
|
|
Development of a system (devices and protocols) to improve biospecimen preservati
|
1R21CA155478-01A1
|
$124,500
|
|
Hrudka, Brian
|
BIOSPECIMEN PROCUREMENT SOLUTIONS, INC.
|
|
Quantitiative MRI of prostate cancer as a biomarker and guide for treatment
|
5U01CA151261-02
|
$356,128
|
|
Fennessy, Fiona
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Nanosystems Biology Cancer Center 2
|
5U54CA151819-02
|
$2,446,327
|
|
HEATH, JAMES
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
|
Cancer Biology Training Grant
|
2T32CA059366-16A2
|
$192,034
|
|
DISTELHORST, CLARK
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case GI SPORE
|
1P50CA150964-01A1
|
$2,140,500
|
|
MARKOWITZ, SANFORD
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Properties and regulation of p53 in tumor cells
|
5R01CA077742-11
|
$307,573
|
|
Prives, Carol
|
COLUMBIA UNIV NEW YORK MORNINGSIDE
|
|
National Center: Multiscale Analysis of Genomic and Cellular Networks (MAGNet)
|
5U54CA121852-07
|
$240,000
|
|
CALIFANO, ANDREA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Mechanism of Action of Retinoic Acid Using CD38
|
1R01CA152870-01A1
|
$325,385
|
|
YEN, ANDREW
|
CORNELL UNIVERSITY ITHACA
|
|
Accountability and the Role of the Principal Investigator in Multicenter Trials
|
5R01CA152110-02
|
$385,711
|
|
JOFFE, STEVEN
|
DANA-FARBER CANCER INSTITUTE
|
|
Clinical Oncology Research Career Development Program
|
5K12CA100639-08
|
$828,018
|
|
LYERLY, HERBERT
|
DUKE UNIVERSITY
|
|
Lincoln University-Fox Chase Partnership in Cancer Research and Training (2 of 2)
|
5P20CA138017-04
|
$377,979
|
|
BECK, JOHN
|
FOX CHASE CANCER CENTER
|
|
Impact of HIV and HHV-8 Co-Infection on Antiretroviral Therapy Efficacy in Africa
|
5R01CA138165-02
|
$297,775
|
|
CASPER, COREY
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Tumor Suppression by the Fbw7 Ubiquitin Ligase
|
5R01CA084069-12
|
$354,300
|
|
CLURMAN, BRUCE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Therapeutic use of HPV L1 Vaccine in Anogenital Neoplasia: VIVA Trial
|
1R01CA213130-01
|
$767,849
|
$383,925
|
MADELEINE, MARGARET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Association between HIV and Survival after Cancer Diagnosis
|
5R03CA153371-02
|
$85,360
|
|
Newcomb, Polly
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Human Herpesvirus-8 Replication and Kaposi Sarcoma Response to Treatment
|
1K23CA150931-01A1
|
$141,301
|
|
Phipps, Warren
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Statistical Methods for Medical Studies
|
2P01CA053996-34
|
$667,410
|
|
PRENTICE, ROSS
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Evaluation of antiangiogenic role of EM011, a novel tubulin-binding agent
|
5R00CA131489-04
|
$241,529
|
|
Aneja, Ritu
|
GEORGIA STATE UNIVERSITY
|
|
Development of Immunotherapeutic Strategies in the Treatment of Lung Cancer
|
5K24CA128953-04
|
$171,205
|
|
ANTONIA, SCOTT
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Visual Programming Tool for Integrated Gene/Protein Networks in Cancer Research
|
5R44CA125807-05
|
$730,407
|
|
Sasinowski, Maciek
|
INCOGEN, INC.
|
|
Epidermal growth factor regulation of miR-125a promotes invasive ovarian cancer
|
5R00CA133190-04
|
$241,530
|
|
Cowden Dahl, Karen
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Proteome Characterization Center: A Genoproteomics Pipeline for Cancer Biomarkers
|
1U24CA160036-01
|
$1,962,728
|
|
CHAN, DANIEL
|
JOHNS HOPKINS UNIVERSITY
|
|
0021.0001 CG 425 METAVIVOR
|
261200800001E
|
$319,219,481
|
$4,525
|
UNKNOWN, UNKNOWN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
Lincoln University-Fox Chase Partnership in Cancer Research and Training 1 of 2
|
5P20CA138068-04
|
$47,400
|
|
Hull, Anna
|
LINCOLN UNIVERSITY
|
|
In-room PET Monitoring of Proton Therapy
|
5R21CA153455-02
|
$353,777
|
|
EL FAKHRI, GEORGES
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Multi-Parameter Monitoring of Breast Cancer Progression and Therapeutic Response
|
5R01CA135650-04
|
|
|
MOORE, ANNA
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Theranostic Nanomedicine for Breast Cancer Prevention and Image-Guided Therapy
|
5K99CA153948-02
|
$123,401
|
|
Rai, Prakash
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Systemic radiotherapy for metastatic melanomas: Innovation of a novel radiopharma
|
5R44CA138041-04
|
$722,670
|
|
Kronauge, James
|
MOLECULAR INSIGHT PHARMACEUTICALS, INC.
|
|
Inherited bone marrow failure syndromes study
|
ZIA CP010144-07130
|
$2,383,555
|
$119,178
|
Alter, Blanche
|
DCEG (NCI)
|
|
Stable Water Isotope Labeling for Imaging of Rapidly Proliferating Cells
|
ZIA BC 011777
|
$24,641
|
$246
|
Buxbaum, Nataliya
|
CCR (NCI)
|
|
Preclinical development and clinical monitoring of adoptive immune therapy
|
ZIC BC 011029
|
$420,830
|
$16,833
|
Hakim, Frances
|
CCR (NCI)
|
|
Tumor infiltrating lymphocyte therapy for human papillomavirus-positive cancers
|
ZIA BC 011478
|
$671,060
|
$13,421
|
Hinrichs, Christian
|
CCR (NCI)
|
|
T-cell receptor gene therapy for human papillomavirus-positive cancers
|
ZIA BC 011479
|
$671,060
|
$13,421
|
Hinrichs, Christian
|
CCR (NCI)
|
|
Continuation of follow-up of DES-exposed cohorts
|
ZIA CP010168-00020
|
$2,165,235
|
$216,523
|
Hoover, Robert
|
DCEG (NCI)
|
|
Papillomavirus Virion Proteins and Vaccines
|
ZIA BC 010579
|
$542,150
|
$54,215
|
Lowy, Douglas
|
CCR (NCI)
|
|
Interaction of Chemical Carcinogens and Chemotherapeutic Agents with DNA
|
ZIA BC 005177
|
$42,643
|
$2,132
|
Poirier, Miriam
|
CCR (NCI)
|
|
Genotoxicity and mitochondrial toxicity of antiretroviral NRTI and PI drugs
|
ZIA BC 010770
|
$79,195
|
$15,839
|
Poirier, Miriam
|
CCR (NCI)
|
|
Papillomavirus Virion Proteins and Vaccines
|
ZIA BC 009052
|
$1,436,901
|
$71,845
|
Schiller, John
|
CCR (NCI)
|
|
EGFR-Targeted Nanoemulsions for Imaging and Therapy of Ovarian Cancer
|
5R43CA144591-02
|
$152,606
|
|
Coleman, Timothy
|
NEMUCORE MEDICAL INNOVATIONS, INC.
|
|
Discovery and Clinical Validation of Cancer Biomarkers Using Printed Glycan Array
|
5U01CA128526-05
|
$404,464
|
|
Huflejt, Margaret
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Training Program in Molecular Oncology and Immunology
|
2T32CA009161-36A1
|
$778,188
|
|
Levy, David
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Chemo-dietary prevention, miRNAs, epigenetic and prostate cancer
|
1R01CA160079-01
|
$461,404
|
|
DAHIYA, RAJVIR
|
NORTHERN CALIFORNIA INSTITUTE RES & EDUC
|
|
Tumor Targeted Nanobins for the Treatment of Metastatic Breast and Ovarian Cancer
|
5U01CA151461-02
|
$433,830
|
|
O'HALLORAN, THOMAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Use of silver nanostructures on microtransponders in ultra-sensitive assay
|
5R44CA132547-04
|
$580,711
|
|
MANDECKI, WLODEK
|
PHARMASEQ, INC.
|
|
Biosensor technology to monitor leukemia-related kinase activity in patient cells
|
1R21CA160129-01
|
$165,931
|
|
Parker, Laurie
|
PURDUE UNIVERSITY WEST LAFAYETTE
|
Total relevant funding to Vaginal for this search: $912,103
|